Nicotinamide Riboside Therapy
Reading Time: 3 minutes
Riboside is gaining renewed attention as a neuroprotective ally in the fight against Parkinson’s disease (PD). With the recent announcement from Niagen Bioscience and emerging trends in AI-driven diagnostics, this …
When Dopamine Misfires in Two Systems
Reading Time: 2 minutes
1. Parkinson’s Alters the Dopamine Pathway — and So Does Bipolar
Parkinson’s disease causes dopaminergic neuron degeneration, particularly in the substantia nigra. This reduces dopamine levels, triggering motor symptoms and affecting …
Read More
Reading Time: 3 minutes
Neurogenesis in Adults: A Breakthrough with Implications for Parkinson’s
Groundbreaking new evidence has emerged that may finally resolve a century-old scientific debate: do human brains continue to produce new neurons in …
Read MoreBrain Aging Slowed by Lifestyle
Reading Time: 4 minutes
🧠 The Promise of Lifestyle-Driven Brain Health
As the science of brain aging advances, one message is ringing clear: how we live each day profoundly shapes how our brain ages. A …
Read MoreBoosting Klotho in Parkinson’s
Reading Time: 3 minutes
Introduction: Why Klotho Matters
Parkinson’s disease (PD) is widely recognized for its motor symptoms, but as the condition progresses, cognitive decline and dementia affect a significant number of patients. The neurodegenerative …
Read More